Substitution reactivity and structural variability induced by tryptamine on the biomimetic rhenium tricarbonyl complex

A series of seven fac-[Re(CO)₃(5Me-Sal-Trypt)(L)] complexes containing tryptamine on the N,O 5-methyl-salicylidene bidentate ligand backbone and where L is MeOH, Py, Imi, DMAP, PPh₃ coordinated to the 6th position have been studied, including the formation of a dinuclear Re₂ cluster. The crystallographic solid state structures show marked similarity in structural tendency, in particular the rigidity of the Re core and the hydrogen bond interactions similar to those found in protein structures. The rates of formation and stability of the complexes were evaluated by rapid time-resolved stopped-flow techniques and the methanol substitution reaction indicates the significant activation induced by the use of the N,O salicylidene bidentate ligand as manifested by the second-order rate constants for the entering nucleophiles. Both linear and limiting kinetics were observed and a systematic evaluation of the kinetics is reported clearly indicating an interchange type of intimate mechanism for the methanol substitution. The anticancer activity of compounds 1–7 was tested on HeLa cells and it was found that all compounds showed similar cytotoxicity where solubility allowed. IC₅₀-values between ca. 11 and 22 μM indicate that some cytotoxicity resides most likely on the salicylidene–tryptamine ligand. The photoluminescence of the seven complexes is similar in maximum emission wavelength with little variation despite the broad range of ligands coordinated to the 6th position on the metal centre.

The biomimetic tryptamine rhenium tricarbonyl complex shows rapid substitution reactivity on the 6th position as well as cytotoxicity and photoluminescence capability induced by the salicylidene bidentate ligand.

Synthesis, characterization and photoinduced CO-release by manganese(i) complexes

Three new photoCORM, two with non two with nonbonding pyridine and one with benzyl group, were synthesised, and their CO-releasing properties evaluated for with regards to their elusive binding mode.

Structures of rhenium(I) complexes with 3-hydroxyflavone and benzhydroxamic acid as O,O'-bidentate ligands and confirmation of π-stacking by solid-state NMR spectroscopy

The synthesis and crystal structures of two new rhenium(I) complexes obtained utilizing benzhydroxamic acid (BHAH) and 3-hydroxyflavone (2-phenylchromen-4-one, FlavH) as bidentate ligands, namely tetraethylammonium fac-(benzhydroxamato-κ²O,O')bromidotricarbonylrhenate(I), (C₈H₂₀N)[ReBr(C₇H₆NO₂)(CO)₃], 1, and fac-aquatricarbonyl(4-oxo-2-phenylchromen-3-olato-κ²O,O')rhenium(I)-3-hydroxyflavone (1/1), [Re(C₁₅H₉O₃)(CO)₃(H₂O)]·C₁₅H₁₀O₃, 3, are reported. Furthermore, the crystal structure of free 3-hydroxyflavone, C₁₅H₁₀O₃, 4, was redetermined at 100 K in order to compare the packing trends and solid-state NMR spectroscopy with that of the solvate flavone molecule in 3. The compounds were characterized in solution by ¹H and ¹³C NMR spectroscopy, and in the solid state by ¹³C NMR spectroscopy using the cross-polarization magic angle spinning (CP/MAS) technique. Compounds 1 and 3 both crystallize in the triclinic space group P-1 with one molecule in the asymmetric unit, while 4 crystallizes in the orthorhombic space group P2₁2₁2₁. Molecules of 1 and 3 generate one-dimensional chains formed through intermolecular interactions. A comparison of the coordinated 3-hydroxyflavone ligand with the uncoordinated solvate molecule and free molecule 4 shows that the last two are virtually completely planar due to hydrogen-bonding interactions, as opposed to the former, which is able to rotate more freely. The differences between the solid- and solution-state ¹³C NMR spectra of 3 and 4 are ascribed to inter- and intramolecular interactions. The study also investigated the potential labelling of both bidentate ligands with the corresponding fac-^99mTc-tricarbonyl synthon. All attempts were unsuccessful and reasons for this are provided.

Crystal structure of 3,5,7-tris(morpholinomethyl)tropolone·0.67 hydrate, C22H33N3O5·0.67H2O

C22H33N3O5·0.67H2O, monoclinic, P21/c, a = 11.9915(6) Å, b = 18.9934(10) Å, c = 10.5332(5) Å, β = 112.155(2)°, V = 2221.91(19) Å3, Z = 4, R gt(F) = 0.0417, wR ref(F 2) = 0.1139, T = 100(2) K.

Crystal structure of fac-hexacarbonylbisμ2-(3-carboxy-3′-carboxylato-2,2′-bipyridine)-κ3N,N′:O-dirhenium(I) tetrahydrate, C30H22N4O18Re2

C30H22N4O18Re2, monoclinic, P21/c (no. 14), a = 10.167(7) Å, b = 17.57(1) Å, c = 19.95(1) Å, β = 98.75(1)°, V = 3522(9) Å3, Z = 4, Rgt(F) = 0.0275, wRref(F2) = 0.0633, T = 100(2) K.

Crystal structure of bis(μ2-2-((3-methylphenyl)imino)methylphenolato-κ2 N,O:O)hexacarbonyldimanganese(I), C34H24Mn2N2O8

C34H24Mn2N2O8, triclinic, P1̅ (no. 2) a = 7.737(5) Å, b = 9.483(5) Å, c = 11.309(5) Å, β = 102.514(5)°, V = 766.6(7) Å3, Z = 1, R gt (F) = 0.0478, wR ref (F 2 ) = 0.1297, T = 100(2) K

Structural comparison of group 7 tricarbonyl complexes of 2-{[2-(1H-imidazol-4-yl)ethyl]iminomethyl}-5-methylphenolate

Two tricarbonyl complexes of rhenium(I) and manganese(I) coordinated by the ligand 2-{[2-(1H-imidazol-4-yl)ethyl]iminomethyl}-5-methylphenolate are reported, viz. fac-tricarbonyl(2-{[2-(1H-imidazol-4-yl-κN(3))ethyl]iminomethyl-κN}-5-methylphenolato-κO)rhenium(I) methanol monosolvate, [Re(C16H14N3O4)(CO)3]·CH3OH, (I), and fac-tricarbonyl(2-{[2-(1H-imidazol-4-yl-κN(3))ethyl]iminomethyl-κN}-5-methylphenolato-κO)manganese(I), fac-[Mn(C16H14N3O4)(CO)3], (II), display facial coordination in a distorted octahedral environment. The crystal structure of (I) is stabilized by O-H···O, N-H···O and C-H···O hydrogen-bond interactions, while that of (II) is stabilized by N-H...O hydrogen-bond interactions only. These interactions result in two-dimensional networks and π-π stacking for both structures.